According to FutureWise analysis the market for avian influenza vaccine in 2023 is US$ 0.14 billion, and is expected to reach US$ 0.22 billion by 2031 at a CAGR of 6.1%.
Avian influenza is an infectious disease that is brought on by the bird flu Type-A virus. Aquatic birds are the main source of the virus. The classification of the avian influenza type A virus as neuraminidase (NA) or hemagglutinin is based on protein remains on the virus surface (HA). It is divided into two groups, highly pathogenic and low pathogenic, based on molecular features. If the virus gets inside the mouth, nose, or eyes, it can harm humans as well. To prevent and treat illness, the avian influenza vaccines contain the antiviral drugs oseltamivir (Tamiflu) and zanamivir (Relenza). It is frequently utilised in birds, including ducks, chickens, geese, and others. Greater government efforts to spread the word about avian influenza and increased funding for private-sector research to create potent avian influenza vaccines could drive market expansion throughout the course of the studied period. Strategic partnerships between private and public organisations, as well as cooperative initiatives in the digitalization of medical aid facilities, may aid in the market's expansion. The rising incidence of diseases in emerging nations may be a factor in the rise in poultry mortality. At the same time, more study is required to develop effective vaccines for disease prevention due to the rising demand for chicken for human consumption. With the aid of gene editing technologies, chickens can be genetically resistant to the avian flu. Additionally, particular laws permit the culling of hens with bird flu. The main forces behind the market expansion for avian influenza vaccines are greater strategic collaborations between the public and private sectors and investments in both.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Avian Influenza Vaccine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Avian Influenza Vaccine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.